Michael Purol Sandbox 1: Difference between revisions
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
{{STRUCTURE_1bd8 | PDB= 1bd8 | SCENE= }} | {{STRUCTURE_1bd8 | PDB= 1bd8 | SCENE= }} | ||
== | ==p19 in the Cell Cycle== | ||
CDK Inhibitor p19INK4d is a | CDK Inhibitor p19INK4d is a cyclin-dependent kinase (CDK) inhibitor in the INK4 family of CDK inhibitors. Progression through the G1 phase of the cell cycle and subsequent entry into the S phase depend on the phosphorylating effects of CDK4 and CDK6. These two CDKs must form cyclin-CDK complexes to phosphorylate the retinoblastoma protein, inhibiting its growth-suppressing function, and triggering an E2F-dependent transcriptional program necessary for entry into S phase. | ||
<scene name='Michael_Purol_Sandbox_1/Lys_62/1'>Lys 62</scene> | <scene name='Michael_Purol_Sandbox_1/Lys_62/1'>Lys 62</scene> |